RxDoctor Payments Data

George Gilbert, MD

Family Medicine · Peoria, ILNPI 1215021100

Payments from drug & device makers

$6,275in general payments, 2019–2025

Across 371 payments — averaging $16.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$567
  • AstraZeneca$556
  • Orexo US, Inc.$522
  • Novartis$508
  • AbbVie$434
  • Gilead$337
  • plus $3K from 49 others

What the payments were for

  • Food & beverage$6,275100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,275 in reported general payments places this provider in the 90th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$42,712
Medicare patients
135
Services billed
674

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban152$104,827
XareltoRivaroxaban92$58,549
JardianceEmpagliflozin69$46,061
OxycontinOxycodone Hcl34$45,907
JanuviaSitagliptin Phosphate59$45,027
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl162$28,527
TrulicityDulaglutide26$26,912
OzempicSemaglutide25$23,932
FarxigaDapagliflozin Propanediol35$19,863
Tresiba Flextouch U-200Insulin Degludec12$17,019
TradjentaLinagliptin17$13,854
MounjaroTirzepatide14$13,683
ZubsolvBuprenorphine Hcl/Naloxone Hcl16$10,370
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$9,502
Potassium Chloride184$7,249

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$567$104,827152 claims
Boehringer IngelheimJardiance, Tradjenta$111$59,91586 claims
Johnson & JohnsonXarelto$103$58,54992 claims
MerckJanuvia$59$45,02759 claims
Lilly USA, LLCTrulicity, Mounjaro$75$40,59540 claims
AstraZenecaFarxiga, Symbicort$556$25,87652 claims
Novo NordiskOzempic$85$23,93225 claims
Orexo US, Inc.Zubsolv$522$10,37016 claims
GSKTrelegy Ellipta$145$9,50213 claims
AbbVieSynthroid$434$1,51913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Peoria

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →